Guohui Xu
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Neoadjuvant therapy for resectable colorectal cancer pulmonary oligometastases: a retrospective cohort study.
Journal: International journal of colorectal disease
Published: April 10, 2025
DWI-based Biologically Interpretable Radiomic Nomogram for Predicting 1-year Biochemical Recurrence after Radical Prostatectomy: A Deep Learning, Multicenter Study.
Journal: Current medical imaging
Published: April 08, 2025
Development and Validation of Nomograms to Predict the Overall Survival and Progression-Free Survival in Patients with Advanced Unresectable Intrahepatic Cholangiocarcinoma.
Journal: Cancer management and research
Published: August 09, 2024
Negative prognostic impact of tumor deposits in stage III colorectal cancer patients.
Journal: PloS one
Published: May 31, 2024
The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study.
Journal: Surgery
Published: January 23, 2024
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Journal: Journal of hepatocellular carcinoma
Published: October 09, 2023
The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.
Journal: Medicine
Published: September 08, 2023
Silencing of peroxiredoxin 2 suppresses proliferation and Wnt/β-catenin pathway, and induces senescence in hepatocellular carcinoma.
Journal: Oncology research
Published: April 21, 2023
Efficacy and safety of PD1/PDL1 inhibitors combined with radiotherapy and anti-angiogenic therapy for solid tumors: A systematic review and meta-analysis.
Journal: Medicine
Published: March 10, 2023
Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
Journal: Frontiers in immunology
Published: December 08, 2022
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Journal: Journal of hepatocellular carcinoma
Published: November 25, 2022
Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis.
Journal: Medicine
Published: November 07, 2022
Last Updated: 09/26/2026